• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细菌微生物组与癌症:发展、诊断、治疗和未来方向。

The bacterial microbiome and cancer: development, diagnosis, treatment, and future directions.

机构信息

Department of Zoology, Faculty of Science, Ain Shams University, Abbassia, Cairo, 11566, Egypt.

出版信息

Clin Exp Med. 2024 Nov 28;25(1):12. doi: 10.1007/s10238-024-01523-9.

DOI:10.1007/s10238-024-01523-9
PMID:39607612
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11604675/
Abstract

The term "microbiome" refers to the collection of bacterial species that reside in the human body's tissues. Sometimes, it is used to refer to all microbial entities (bacteria, viruses, fungi, and others) which colonize the human body. It is now generally acknowledged that the microbiome plays a critical role in the host's physiological processes and general well-being. Changes in the structure and/or function of the microbiome (dysbiosis) are linked to the development of many diseases including cancer. The claim that because of their negatively charged membrane, cancer cells are more vulnerable to some bacteria than normal cells and that is how the link between these bacteria and cancer evolved has been refuted. Furthermore, the relationship between the microbiome and cancer is more evident in the emerging field of cancer immunotherapy. In this narrative review, we detailed the correlation between the presence/absence of specific bacterial species and the development, diagnosis, prognosis, and treatment of some types of cancer including colorectal, lung, breast, and prostate cancer. In addition, we discussed the mechanisms of microbiome-cancer interactions including genotoxin production, the role of free radicals, modification of signaling pathways in host cells, immune modulation, and modulation of drug metabolism by microbiome. Future directions and clinical application of microbiome in the early detection, prognosis, and treatment of cancer emphasizing on the role of fecal transplantation, probiotics, prebiotics, and microbiome biomarkers were also considered.

摘要

“微生物组”一词指的是存在于人体组织中的细菌种类集合。有时,它也被用来指代定植于人体的所有微生物实体(细菌、病毒、真菌等)。现在人们普遍认为,微生物组在宿主的生理过程和整体健康中起着关键作用。微生物组的结构和/或功能的变化(失调)与许多疾病的发展有关,包括癌症。有人声称,由于其带负电荷的膜,癌细胞比正常细胞更容易受到某些细菌的攻击,而这些细菌与癌症之间的联系就是这样演变而来的,这种说法已经被驳斥。此外,在癌症免疫治疗这一新兴领域,微生物组与癌症之间的关系更为明显。在这篇叙述性综述中,我们详细描述了特定细菌种类的存在/缺失与某些类型癌症(包括结直肠癌、肺癌、乳腺癌和前列腺癌)的发展、诊断、预后和治疗之间的相关性。此外,我们还讨论了微生物组-癌症相互作用的机制,包括遗传毒素的产生、自由基的作用、宿主细胞信号通路的修饰、免疫调节以及微生物组对药物代谢的调节。我们还考虑了微生物组在癌症早期检测、预后和治疗中的未来方向和临床应用,强调了粪便移植、益生菌、益生元和微生物组生物标志物的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/846a/11604675/bc4b43b6a9a8/10238_2024_1523_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/846a/11604675/b030ecf8968e/10238_2024_1523_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/846a/11604675/67f33d22d81b/10238_2024_1523_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/846a/11604675/69f824f6e43c/10238_2024_1523_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/846a/11604675/59d0b1d4fab8/10238_2024_1523_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/846a/11604675/bc4b43b6a9a8/10238_2024_1523_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/846a/11604675/b030ecf8968e/10238_2024_1523_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/846a/11604675/67f33d22d81b/10238_2024_1523_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/846a/11604675/69f824f6e43c/10238_2024_1523_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/846a/11604675/59d0b1d4fab8/10238_2024_1523_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/846a/11604675/bc4b43b6a9a8/10238_2024_1523_Fig5_HTML.jpg

相似文献

1
The bacterial microbiome and cancer: development, diagnosis, treatment, and future directions.细菌微生物组与癌症:发展、诊断、治疗和未来方向。
Clin Exp Med. 2024 Nov 28;25(1):12. doi: 10.1007/s10238-024-01523-9.
2
Modulating the gut microbiota by probiotics, prebiotics, postbiotics, and fecal microbiota transplantation: An emerging trend in cancer patient care.通过益生菌、益生元、后生元及粪便微生物群移植调节肠道微生物群:癌症患者护理中的一个新趋势。
Biochim Biophys Acta Rev Cancer. 2023 Nov;1878(6):188990. doi: 10.1016/j.bbcan.2023.188990. Epub 2023 Sep 22.
3
Microbiome's Universe: Impact on health, disease and cancer treatment.微生物组的世界:对健康、疾病及癌症治疗的影响。
J Biotechnol. 2024 Sep 10;392:161-179. doi: 10.1016/j.jbiotec.2024.07.002. Epub 2024 Jul 14.
4
Dysbiosis of human microbiome and infectious diseases.人类微生物组失调与传染病。
Prog Mol Biol Transl Sci. 2022;192(1):33-51. doi: 10.1016/bs.pmbts.2022.06.016. Epub 2022 Jul 21.
5
The role of the gut microbiota in tumor, immunity, and immunotherapy.肠道微生物群在肿瘤、免疫和免疫治疗中的作用。
Front Immunol. 2024 Jun 5;15:1410928. doi: 10.3389/fimmu.2024.1410928. eCollection 2024.
6
The role of the bacterial microbiome in the treatment of cancer.细菌微生物组在癌症治疗中的作用。
BMC Cancer. 2021 Aug 19;21(1):934. doi: 10.1186/s12885-021-08664-0.
7
Significance of the Gut Microbiome for Viral Diarrheal and Extra-Intestinal Diseases.肠道微生物组对病毒性腹泻和肠道外疾病的意义。
Viruses. 2021 Aug 12;13(8):1601. doi: 10.3390/v13081601.
8
Therapeutic potential of microbiome modulation in reproductive cancers.微生物群调节在生殖系统癌症中的治疗潜力
Med Oncol. 2025 Apr 6;42(5):152. doi: 10.1007/s12032-025-02708-2.
9
Therapeutic potential of probiotics in gut microbial homeostasis and Rheumatoid arthritis.益生菌在肠道微生物群稳态和类风湿关节炎中的治疗潜力。
Int Immunopharmacol. 2024 Aug 20;137:112501. doi: 10.1016/j.intimp.2024.112501. Epub 2024 Jun 16.
10
Exploring the role of gut microbiota in antibiotic resistance and prevention.探索肠道微生物群在抗生素耐药性及预防中的作用。
Ann Med. 2025 Dec;57(1):2478317. doi: 10.1080/07853890.2025.2478317. Epub 2025 Mar 17.

引用本文的文献

1
The microbiome-cancer axis as a hidden contributor to early-onset tumorigenesis.微生物群-癌症轴作为早发性肿瘤发生的一个潜在促成因素。
Med Oncol. 2025 Sep 6;42(10):464. doi: 10.1007/s12032-025-02988-8.
2
The Impact of the Microbiota on the Immune Response Modulation in Colorectal Cancer.微生物群对结直肠癌免疫反应调节的影响
Biomolecules. 2025 Jul 14;15(7):1005. doi: 10.3390/biom15071005.
3
Exploring the gut microbiome's influence on cancer-associated anemia: Mechanisms, clinical challenges, and innovative therapies.探索肠道微生物群对癌症相关性贫血的影响:机制、临床挑战及创新疗法。

本文引用的文献

1
Intestinal Dysbiosis: Microbial Imbalance Impacts on Colorectal Cancer Initiation, Progression and Disease Mitigation.肠道菌群失调:微生物失衡对结直肠癌的发生、发展及疾病缓解的影响
Biomedicines. 2024 Mar 26;12(4):740. doi: 10.3390/biomedicines12040740.
2
Integrated analysis of gut microbiota and metabolomic profiling in colorectal cancer metastasis.结直肠癌转移中肠道微生物群与代谢组学分析的整合研究
Environ Toxicol. 2024 Oct;39(10):4467-4478. doi: 10.1002/tox.24228. Epub 2024 Mar 14.
3
The potential role of the microbiota in prostate cancer pathogenesis and treatment.
World J Gastrointest Pharmacol Ther. 2025 Jun 5;16(2):105375. doi: 10.4292/wjgpt.v16.i2.105375.
4
The Microbiome Connection: A Common Pathway Linking Cancer and Heart Failure.微生物组关联:连接癌症与心力衰竭的共同途径。
Biomedicines. 2025 May 25;13(6):1297. doi: 10.3390/biomedicines13061297.
5
The Role of G Protein-Coupled Receptors in the Regulation of Orthopaedic Diseases by Gut Microbiota.G蛋白偶联受体在肠道微生物群对骨科疾病的调节作用中所扮演的角色。
Nutrients. 2025 May 16;17(10):1702. doi: 10.3390/nu17101702.
6
Microbiota as diagnostic biomarkers: advancing early cancer detection and personalized therapeutic approaches through microbiome profiling.微生物群作为诊断生物标志物:通过微生物组分析推进早期癌症检测和个性化治疗方法。
Front Immunol. 2025 May 8;16:1559480. doi: 10.3389/fimmu.2025.1559480. eCollection 2025.
7
Harnessing the Microbiome: CRISPR-Based Gene Editing and Antimicrobial Peptides in Combating Antibiotic Resistance and Cancer.利用微生物组:基于CRISPR的基因编辑和抗菌肽对抗抗生素耐药性和癌症
Probiotics Antimicrob Proteins. 2025 May 16. doi: 10.1007/s12602-025-10573-8.
8
Unveiling the microbial orchestra: exploring the role of microbiota in cancer development and treatment.揭开微生物的“管弦乐队”之谜:探索微生物群在癌症发生发展及治疗中的作用。
Discov Oncol. 2025 Apr 30;16(1):646. doi: 10.1007/s12672-025-02352-2.
9
Microbiome Integrity Enhances the Efficacy and Safety of Anticancer Drug.微生物群完整性增强抗癌药物的疗效和安全性。
Biomedicines. 2025 Feb 10;13(2):422. doi: 10.3390/biomedicines13020422.
10
Unraveling the Role of in Colorectal Cancer: Molecular Mechanisms and Pathogenic Insights.解析[具体内容]在结直肠癌中的作用:分子机制与致病见解 (注:原文中“of”后面缺少具体内容)
Cancers (Basel). 2025 Jan 23;17(3):368. doi: 10.3390/cancers17030368.
肠道菌群在前列腺癌发病机制和治疗中的潜在作用。
Nat Rev Urol. 2023 Dec;20(12):706-718. doi: 10.1038/s41585-023-00795-2. Epub 2023 Jul 25.
4
Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor-induced colitis.粪便微生物移植通过改变微生物组对难治性免疫检查点抑制剂诱导的结肠炎有效。
Sci Transl Med. 2023 Jun 14;15(700):eabq4006. doi: 10.1126/scitranslmed.abq4006.
5
Pathobionts in the tumour microbiota predict survival following resection for colorectal cancer.肿瘤微生物群中的条件致病菌可预测结直肠癌切除术后的生存情况。
Microbiome. 2023 May 8;11(1):100. doi: 10.1186/s40168-023-01518-w.
6
promotes colorectal carcinogenesis by deregulating intestinal immunity and inducing a mucus-degrading microbiota signature.促进结直肠癌的发生发展,其机制是通过扰乱肠道免疫和诱导黏液降解的微生物群特征。
Gut. 2023 Jul;72(7):1258-1270. doi: 10.1136/gutjnl-2022-328075. Epub 2023 Apr 4.
7
No evidence for a common blood microbiome based on a population study of 9,770 healthy humans.没有证据表明存在基于 9770 名健康人群的通用血液微生物组。
Nat Microbiol. 2023 May;8(5):973-985. doi: 10.1038/s41564-023-01350-w. Epub 2023 Mar 30.
8
The Gut-Prostate Axis: A New Perspective of Prostate Cancer Biology through the Gut Microbiome.肠道-前列腺轴:通过肠道微生物群对前列腺癌生物学的新视角
Cancers (Basel). 2023 Feb 21;15(5):1375. doi: 10.3390/cancers15051375.
9
Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities.结直肠癌中的肠道微生物群:生物学作用与治疗机遇
Cancers (Basel). 2023 Jan 30;15(3):866. doi: 10.3390/cancers15030866.
10
Microbiome and Prostate Cancer: A Novel Target for Prevention and Treatment.微生物组与前列腺癌:预防和治疗的新靶点。
Int J Mol Sci. 2023 Jan 12;24(2):1511. doi: 10.3390/ijms24021511.